Literature DB >> 2737716

Angiotensin II induces c-fos expression in smooth muscle via transcriptional control.

A J Naftilan1, R E Pratt, C S Eldridge, H L Lin, V J Dzau.   

Abstract

Angiotensin II (Ang II) has been shown to cause hypertrophy of cultured quiescent rat aortic smooth muscle cells. This observation along with the recent demonstration of angiotensinogen messenger RNA (mRNA) in the vessel wall has led us to postulate a role for Ang II in hypertensive smooth muscle hypertrophy. One of the earliest responses in a wide variety of cells in response to a growth-promoting agent is the induction of the proto-oncogene c-fos. To investigate the mechanism of the action of Ang II, we investigated the effect of Ang II on the expression of the c-fos gene in rat aortic smooth muscle cells that were made quiescent by being grown in a defined serum-free media for 48 hours. Ang II (10(-6)-10(-10) M) resulted in a dose-dependent increase in c-fos mRNA expression. This induction was angiotensin-receptor specific since it was completely abolished by the competitive inhibitor saralasin. Inhibition of protein synthesis did not block the rise in c-fos mRNA expression; it resulted in a superinduction and stabilization of the c-fos mRNA. Using a nuclear runoff transcription assay, we demonstrated that Ang II stimulated the transcription rate of the c-fos gene. This activation of c-fos gene expression may be an important mechanism in the angiotensin-induced smooth muscle hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2737716     DOI: 10.1161/01.hyp.13.6.706

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  29 in total

Review 1.  Angiotensin and calcium signaling in the pituitary and hypothalamus.

Authors:  Cecilia Suárez; Isabel García Tornadú; Carolina Cristina; Jorge Vela; Arturo González Iglesias; Carlos Libertun; Graciela Díaz-Torga; Damasia Becu-Villalobos
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 2.  Age-related changes in cardiac physiology. Can they be postponed or treated by drugs?

Authors:  A Svanborg
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

Review 3.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

4.  Parallel regulation of arginine transport and nitric oxide synthesis by angiotensin II in vascular smooth muscle cells role of protein kinase C.

Authors:  M Rivera-Correa; P I Altieri; N Escobales
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

Review 5.  Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor.

Authors:  A R Brasier; M Jamaluddin; Y Han; C Patterson; M S Runge
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

6.  Induction of the proto-oncogene c-jun by angiotensin II.

Authors:  A J Naftilan; G K Gilliland; C S Eldridge; A S Kraft
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

7.  Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling.

Authors:  Yumei Zhan; Courtney Brown; Elizabeth Maynard; Aleksandra Anshelevich; Weihua Ni; I-Cheng Ho; Peter Oettgen
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

8.  Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon.

Authors:  B D Hoit; Y Shao; A Kinoshita; M Gabel; A Husain; R A Walsh
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

Authors:  H Itoh; M Mukoyama; R E Pratt; G H Gibbons; V J Dzau
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues.

Authors:  T Vago; M Bevilacqua; F Conci; G Baldi; E Ongini; E Chebat; A Monopoli; G Norbiato
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.